TrialBlood2009

Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.

Shannon P Hilchey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.